Sedation with 4-hydroxybutyric acid: A potential pitfall in the diagnosis of SSADH deficiency

Nicole I. Wolf, D. Haas, G. F. Hoffmann, C. Jakobs, G. S. Salomons, R. A. Wevers, U. F. Engelke, D. Rating

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Scopus)

Abstract

Deficiency of succinic semialdehyde dehydrogenase (SSADH) is a rare neurometabolic disorder with accumulation of 4-hydroxybutyric acid (4-HBA) as a biochemical hallmark. We present a boy with an unresolved severe neurological disorder and intermittent elevation of 4-HBA in serum and CSF which was later shown to result from iatrogenic administration of 4-HBA for sedation purposes.

Original languageEnglish
Pages (from-to)291-293
Number of pages3
JournalJournal of inherited metabolic disease
Volume27
Issue number2
DOIs
Publication statusPublished - 2004

Cite this